Search company, investor...

Founded Year

2016

Stage

Series D | Alive

Total Raised

$193.3M

Valuation

$0000 

Last Raised

$192M | 5 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-80 points in the past 30 days

About Orca Bio

Orca Bio is a clinical-stage biotechnology company focused on developing high precision allogeneic cell therapy products for the healthcare sector. The company's main offerings include proprietary therapeutic mixtures of immune and stem cells intended to replace diseased blood and immune systems with healthy ones, aiming to transform allogeneic cell therapy with better outcomes and fewer risks. It was founded in 2016 and is based in Menlo Park, California.

Headquarters Location

3475 Edison Way Suite B

Menlo Park, California, 94025,

United States

650-246-9601

Loading...

Loading...

Expert Collections containing Orca Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Orca Bio is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,257 items

Latest Orca Bio News

Orca Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025

MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that Ivan Dimov, Ph.D., Orca Bio’s co-founder and chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The company presentation will take place on Monday, January 13, 2025, at 8:00AM PST at the Westin St. Francis in the Golden Gate Room on the 32nd floor.

Orca Bio Frequently Asked Questions (FAQ)

  • When was Orca Bio founded?

    Orca Bio was founded in 2016.

  • Where is Orca Bio's headquarters?

    Orca Bio's headquarters is located at 3475 Edison Way, Menlo Park.

  • What is Orca Bio's latest funding round?

    Orca Bio's latest funding round is Series D.

  • How much did Orca Bio raise?

    Orca Bio raised a total of $193.3M.

  • Who are the investors of Orca Bio?

    Investors of Orca Bio include DCVC, Kaiser Permanente, Mubadala Investment Company, 8VC, Illinois Municipal Retirement Fund and 6 more.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.